Gianluca Rotondano
Gianluca Rotondano has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Bucci
Pediatric Gastroenterology and Endoscopy Unit, Department of Pediatric Specialties, Santobono Children’s Hospital, 80129 Naples, Italy
2 shared publications - Maria Antonia Bianco
Division of Gastroenterology, Hospital, Torre del Greco, Italy
2 shared publications Alfonso Tempesta
Istituto Nazionale per lo studio e la cura dei tumori “Fondazione Giovanni Pascale” - IRCCS
1 shared publication- Andrea Belli
Istituto Nazionale Tumori di Napoli, IRCCS “G. Pascale”, Via Mariano Semmola, 80131 Naples, Italy
1 shared publication - Antonio Avallone
Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
1 shared publication - Carolina Ciacci
Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84081 Salerno, Italy
1 shared publication
Latest Publications
- 29 December 2015
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 31 (3) , 587-592
Surgery has a key role for quality assurance of colorectal cancer screening programs: impact of the third level multidisciplinary team on lymph nodal staging
From 2011 to 2013 in the area of the Naples 3 public health district (ASL-NA3), a colorectal cancer screening program (CCSP) was developed. In order to stress the need of quality assurance procedures for surgery and pathology, a third level oncologic pathway was added and set up at a referral colorectal cancer center (RC). Lymph nodal (LN) harvesting, as a process indicator, and nodal positivity were adopted for an interim analysis. The program was implemented by a series of audit meetings and a double type of multidisciplinary team (MDT): “horizontal” and “vertical.” Three hundred and forty colorectal cancer (CRC) patients underwent surgery: 119 chose to be operated at the RC (Gr In), 65 were operated at 22 district hospitals (DH) (Gr Out), and 156 symptomatic not screened patients were operated at the RC (Gr Sym). Statistical analysis revealed differences between Gr In and Gr Out colon groups both for LN harvesting (median of 26 and 11, respectively, P = 0.0001), and for nodal positivity after the first screening round (34.78 and 19.45 %, respectively, P = 0.0169). Results were all the more significant in a subset analysis on early T stage colon subgroups (In vs Out) both for LN harvesting (P < 0.0001) and nodal positivity (P < 0.0001). xSignificant differences between RC and DHs were found, particularly for early-stage CRC patients. LN harvesting should be considered as a surrogate marker of quality assurance for at least screening hospitals for “minimum best” standard of care. This should lead to set up a third level in any CCSP.
- 29 December 2015
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 31 (3) , 587-592
Surgery has a key role for quality assurance of colorectal cancer screening programs: impact of the third level multidisciplinary team on lymph nodal staging
From 2011 to 2013 in the area of the Naples 3 public health district (ASL-NA3), a colorectal cancer screening program (CCSP) was developed. In order to stress the need of quality assurance procedures for surgery and pathology, a third level oncologic pathway was added and set up at a referral colorectal cancer center (RC). Lymph nodal (LN) harvesting, as a process indicator, and nodal positivity were adopted for an interim analysis. The program was implemented by a series of audit meetings and a double type of multidisciplinary team (MDT): “horizontal” and “vertical.” Three hundred and forty colorectal cancer (CRC) patients underwent surgery: 119 chose to be operated at the RC (Gr In), 65 were operated at 22 district hospitals (DH) (Gr Out), and 156 symptomatic not screened patients were operated at the RC (Gr Sym). Statistical analysis revealed differences between Gr In and Gr Out colon groups both for LN harvesting (median of 26 and 11, respectively, P = 0.0001), and for nodal positivity after the first screening round (34.78 and 19.45 %, respectively, P = 0.0169). Results were all the more significant in a subset analysis on early T stage colon subgroups (In vs Out) both for LN harvesting (P < 0.0001) and nodal positivity (P < 0.0001). xSignificant differences between RC and DHs were found, particularly for early-stage CRC patients. LN harvesting should be considered as a surrogate marker of quality assurance for at least screening hospitals for “minimum best” standard of care. This should lead to set up a third level in any CCSP.
- 1 July 2015
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 25 (3) , 509-522
Injection and Cautery Methods for Nonvariceal Bleeding Control
- 1 July 2015
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 25 (3) , 509-522
Injection and Cautery Methods for Nonvariceal Bleeding Control
- 1 October 2014
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 80 (4) , 566-576.e2
Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies
- 1 October 2014
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 80 (4) , 566-576.e2
Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studies
- 4 May 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (05) , 460
“Endoscopic resection” of superficial gastrointestinal neoplasia: a single key opening all the doors
We have read with great interest the position statement by Deprez et al. on the current practice with endoscopic submucosal dissection (ESD) in Europe [ 1 ]. The great effort made by the panel of experts should definitely be commended, as the article is extremely clear and gives a very balanced perspective on the potential role of ESD. The training and educational needs, as well as the technical proficiency required to safely perform this technique in standard practice are sharply focused and correctly addressed. In particular, we were very pleased to read the following statement. “The terms ‘EMR’ or ‘mucosectomy’ are in fact inappropriate, as resection includes a part of the submucosa. They should therefore be replaced by the term ‘endoscopic resection.’”[ 1 ]. In fact, in this very Journal we first proposed the simplified, unifying term of “endoscopic resection” to comprehensively include all of the previous different terminologies so far adopted, from polypectomy to submucosal dissection [ 2 ]. In our opinion, these terms merely represent diverse technical modalities of performance of the same procedure. Our semantic input was soon warmly welcomed by the Japanese authors in their reply letter: “…these methods can be unified under the special term of ‘endoscopic resection.’ We think that the unified term should be considered for the technique to dissect submucosa by special dissecting devices. … We hope that the term ‘endoscopic resection’ and its definition will be discussed at international conferences in the near future.” [ 3 ]. We have always believed that a single term would be advisable to simplify the description of these complex procedures. To see that now our view is also shared by renowned European experts in the field strengthens our conviction in the use of a simplified unifying term.
- 4 May 2011
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 43 (05) , 460
“Endoscopic resection” of superficial gastrointestinal neoplasia: a single key opening all the doors
We have read with great interest the position statement by Deprez et al. on the current practice with endoscopic submucosal dissection (ESD) in Europe [ 1 ]. The great effort made by the panel of experts should definitely be commended, as the article is extremely clear and gives a very balanced perspective on the potential role of ESD. The training and educational needs, as well as the technical proficiency required to safely perform this technique in standard practice are sharply focused and correctly addressed. In particular, we were very pleased to read the following statement. “The terms ‘EMR’ or ‘mucosectomy’ are in fact inappropriate, as resection includes a part of the submucosa. They should therefore be replaced by the term ‘endoscopic resection.’”[ 1 ]. In fact, in this very Journal we first proposed the simplified, unifying term of “endoscopic resection” to comprehensively include all of the previous different terminologies so far adopted, from polypectomy to submucosal dissection [ 2 ]. In our opinion, these terms merely represent diverse technical modalities of performance of the same procedure. Our semantic input was soon warmly welcomed by the Japanese authors in their reply letter: “…these methods can be unified under the special term of ‘endoscopic resection.’ We think that the unified term should be considered for the technique to dissect submucosa by special dissecting devices. … We hope that the term ‘endoscopic resection’ and its definition will be discussed at international conferences in the near future.” [ 3 ]. We have always believed that a single term would be advisable to simplify the description of these complex procedures. To see that now our view is also shared by renowned European experts in the field strengthens our conviction in the use of a simplified unifying term.